Solute carrier NTCP regulates innate antiviral immune responses targeting Hepatitis C virus infection of hepatocytes

Eloi R Verrier, Che C Colpitts, Charlotte Bach, Laura Heydmann, Laetitia Zona, Fei Xiao, Christine Thumann, Emilie Crouchet, Raphaël Gaudin, Camille Sureau, François-Loïc Cosset, Jane A McKeating, Patrick Pessaux, Yujin Hoshida, Catherine Schuster, Mirjam B Zeisel, Thomas F Baumert

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)
115 Downloads (Pure)

Abstract

Chronic hepatitis B, C, and D virus (HBV, HCV, and HDV) infections are the leading causes of liver disease and cancer worldwide. Recently, the solute carrier and sodium taurocholate co-transporter NTCP has been identified as a receptor for HBV and HDV. Here, we uncover NTCP as a host factor regulating HCV infection. Using gain- and loss-of-function studies, we show that NTCP mediates HCV infection of hepatocytes and is relevant for cell-to-cell transmission. NTCP regulates HCV infection by augmenting the bile-acid-mediated repression of interferon-stimulated genes (ISGs), including IFITM3. In conclusion, our results uncover NTCP as a mediator of innate antiviral immune responses in the liver, and they establish a role for NTCP in the infection process of multiple viruses via distinct mechanisms. Collectively, our findings suggest a role for solute carriers in the regulation of innate antiviral responses, and they have potential implications for virus-host interactions and antiviral therapies.

Original languageEnglish
Pages (from-to)1357-1368
Number of pages12
JournalCell Reports
Volume17
Issue number5
DOIs
Publication statusPublished - 25 Oct 2016

Fingerprint

Dive into the research topics of 'Solute carrier NTCP regulates innate antiviral immune responses targeting Hepatitis C virus infection of hepatocytes'. Together they form a unique fingerprint.

Cite this